Ontology highlight
ABSTRACT: Objectives
The aim of the Patient preferences to Assess Value IN Gene therapies (PAVING) study was to investigate trade-offs that adult Belgian people with haemophilia (PWH) A and B are willing to make when choosing between prophylactic factor replacement therapy (PFRT) and gene therapy.Methods
The threshold technique was used to quantify the minimum acceptable benefit (MAB) of a switch from PFRT to gene therapy in terms of 'Annual bleeding rate' (ABR), 'Chance to stop prophylaxis' (STOP), and 'Quality of life' (QOL). The design was supported by stakeholder involvement and included an educational tool on gene therapy. Threshold intervals were analysed using interval regression models in Stata 16.Results
A total of 117 PWH completed the survey. Mean thresholds were i
SUBMITTER: van Overbeeke E
PROVIDER: S-EPMC9293173 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature